Annovis Bio got a warning from the NYSE for not meeting listing rules because its value dropped too low.

Oct 31, 2026, 9:34 AM ETTroubleRead the original at globenewswire.com

Bad for ANVS

Annovis Bio received an NYSE notice after its market value and stockholders' equity both fell below $50 million. It has time to address the problem and can keep trading, but the risk of losing its listing makes the news unfavorable.

ANVS · Annovis Bio, Inc.

AI read · Bad for ANVS

The AI's read

The notice raises the risk that Annovis Bio could lose its NYSE listing if it cannot meet the exchange's rules. That could shake investor confidence. The company has 45 days to submit a plan and 9 months to regain compliance. Its operations and debt agreements are unchanged, and its shares can keep trading during that time. Those protections soften the blow, but do not erase the listing risk.

Get alerts for ANVS

Follow Annovis Bio, Inc. (ANVS) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for ANVS

Free on the App Store and Google Play, or on the web.